Cargando…
Feasibility of chemosensitivity testing in soft tissue sarcomas
BACKGROUND: Soft tissue sarcomas comprise less than 1% of all solid malignancies. The presentation and behavior of these tumors differs depending on location and histological characteristics. Standard therapy consists of complete surgical resection in combination with adjuvant radiotherapy. The role...
Autores principales: | Lehnhardt, Marcus, Muehlberger, Thomas, Kuhnen, Cornelius, Brett, Daniel, Steinau, Hans U, Jafari, Hamid Joneidi, Steinstraesser, Lars, Müller, Oliver, Homann, Heinz H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087896/ https://www.ncbi.nlm.nih.gov/pubmed/15836792 http://dx.doi.org/10.1186/1477-7819-3-20 |
Ejemplares similares
-
Alveolar soft part sarcoma: clinicopathological findings in a series of 11 cases
por: Daigeler, Adrien, et al.
Publicado: (2008) -
Clinicopathological findings in a case series of extrathoracic solitary fibrous tumors of soft tissues
por: Daigeler, Adrien, et al.
Publicado: (2006) -
Malignant fibrous histiocytoma—pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot study
por: Daigeler, Adrien, et al.
Publicado: (2009) -
Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways
por: Lehnhardt, Marcus, et al.
Publicado: (2005) -
Merkel cell carcinoma metastasis and dermatofibrosarcoma protuberans presenting as a collision tumour: a case report and review of the literature
por: Tilkorn, Daniel-Johannes, et al.
Publicado: (2009)